ClinicalTrials.gg
RecruitingNCT07561372Updated Nov 6, 2026

Adaptive Recruitment Curve Analysis Using Bayesian Modeling

An interventional study of Algorithm: Uniform Sampling and Algorithm: hbMEP-adaptive algorithm (version 1) in Modeling of Recruitment Curves, sponsored by Columbia University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Columbia University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Nov 6, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are critical for monitoring the state of the nervous system during therapies like transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS).

This study tests a new, real-time computational approach based on our previously developed methods (Hierarchical Bayesian models) to estimate these recruitment curves more efficiently. The primary goal is to use this model to dynamically guide the experiment, automatically selecting the optimal stimulation intensities to test.

The investigators hypothesize that this optimized approach will accurately estimate the entire recruitment curve, or specific targets components of it like the motor threshold, using significantly fewer samples than standard methods. By reducing the number of measurements required, this approach aims to decrease experimental time and minimize participant burden, making future TMS and SCS therapies and experiments more feasible and efficient.

Read the detailed description

Transcranial magnetic stimulation and other types of neurostimulation play a crucial role in advancing the understanding and manipulation of neural activity for both research and therapeutic purposes. The proposed approach to sampling recruitment curves in real-time promises to significantly improve the efficiency and precision of experiments that use electrical or electromagnetic stimulation techniques, reducing the experimental burden for participants as well as experimenters. By enhancing experimental efficiency in multiple experimental settings and techniques, this research directly contributes to accelerating the translation of scientific discoveries into clinical applications. This study will benchmark the relative performance of different methods against each other by testing existing and proposed algorithms using neurostimulation in people, and comparing the resultant estimates in recruitment curve parameters, and the number of samples required to reach predefined tolerances on these parameters.

02

Conditions studied

  • Modeling of Recruitment Curves

Keywords

  • TMS
  • SCS
  • SCI
  • Hierarchical Bayesian
  • Motor threshold
  • Transcranial Magnetic Stimulation
  • Spinal cord stimulation
  • Evoked Potentials
03

In context

Lead sponsor

Columbia University is the lead sponsor of 1,136 studies on the registry; 194 are open to participants now.

Of its 182 completed or terminated interventional studies of FDA-regulated products, 150 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adult volunteers aged 18 years and older.
  • Able to understand study procedures and provide written .

Exclusion criteria

Exclusion Criteria:

  • 1. History of adverse reaction to Transcranial Magnetic Stimulation (TMS) or non-invasive neurostimulation.
  • 2. History of seizures, epilepsy, or family history of epilepsy.
  • 3. History of stroke, brain injury, or illness causing brain injury.
  • 4. History of head injury or neurosurgery.
  • 5. History of neurological diseases, or central nervous system lesions.
  • 6. Presence of metallic implants or foreign bodies in the head (outside of dental work/fillings).
  • 7. Presence of implanted electronic or medical devices (e.g., cardiac pacemakers, medical pumps, implanted stimulators).
  • 8. Current pregnancy or possibility of pregnancy.
  • 9. Currently taking medications that alter cortical excitability or lower seizure threshold.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (estimated)

Study arms

  • Experimental
    Test of developed methods

    Participants undergo distinct experiments within a single session to compare different neurostimulation sampling algorithms. Each experiment involves recruitment curve sampling with different methods (e.g., Uniform, Expected Information Gain) to evaluate the accuracy and efficiency of motor threshold.

    Other: Algorithm: Uniform Sampling · Other: Algorithm: hbMEP-adaptive algorithm (version 1) · Other: Algorithm: hbMEP-adaptive algorithm (version 2) · Other: ML-PEST · Device: MagPro X100 Transcranial Magnetic Stimulation · Device: Digitimer DS8R Transcutaneous Electrical stimulation

Interventions

  • OtherAlgorithm: Uniform Sampling

    Standard uniform distribution sampling used as a baseline comparison.

  • OtherAlgorithm: hbMEP-adaptive algorithm (version 1)

    An active sampling algorithm for recruitment curve estimation.

  • OtherAlgorithm: hbMEP-adaptive algorithm (version 2)

    An alternative active sampling algorithm for recruitment curve estimation.

  • OtherML-PEST

    Algorithm: Adaptive threshold hunting using the Parameter Estimation by Sequential Testing (PEST) algorithm.

  • DeviceMagPro X100 Transcranial Magnetic Stimulation

    The proposed algorithms will deliver stimulation by using this magnetic stimulation methodology.

  • DeviceDigitimer DS8R Transcutaneous Electrical stimulation

    The proposed algorithms will deliver stimulation by using this electrical stimulation methodology.

06

What researchers measure

Primary outcomes

  1. Number of stimuli to reach a pre-defined threshold error

    Number of stimuli required for the compared methods to reach a pre-defined error threshold relative to the ground truth, computed from recruitment curves fitted after sampling using aggregated data.

    Time frame: Through completion of the study visit, 2-4 hours.

  2. Number of stimuli to reach a pre-defined predictive curve error

    Number of stimuli required for the compared methods to reach a pre-defined error threshold relative to the ground truth, computed from recruitment curves fitted after sampling using aggregated data.

    Time frame: Through completion of the study visit, 2-4 hours.

Secondary outcomes

  1. Mean absolute error in a given parameter (e.g. threshold, predictive curve, slope) for a given number of stimuli

    The error of the methods under comparison, with the ground truth computed from recruitment curves fitted subsequent to sampling using aggregated data.

    Time frame: Through completion of the study visit, 2-4 hours.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Tyagi V, Murray LM, Asan AS, Mandigo C, Virk MS, Harel NY, Carmel JB, McIntosh JR. Hierarchical Bayesian estimation of motor-evoked potential recruitment curves yields accurate and robust estimates. Brain Stimul. 2025 Nov-Dec;18(6):1855-1870. doi: 10.1016/j.brs.2025.09.008. Epub 2025 Sep 18. PubMed 40975380 ↗

Individual participant data

Plan to share: Yes — De-identified MEP data and analysis code and algorithms.

Supporting information: Analytic code

Time frame: Together with publication at the end of this study (04/2027).

Access criteria: Open access repository (e.g. Zenodo and Github).

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2026
First posted
May 1, 2026
StartActual
Sep 25, 2026
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Sep 25, 2026 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Start date Sep 1, 2026→Sep 25, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07561372
Responsible party
James McIntosh (Associate Research Scientist, Columbia University) — Principal investigator
First posted
May 1, 2026
Start date
Sep 25, 2026
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

James R McIntosh, PhD
Contact
jrm2263@cumc.columbia.edu
+19294352335
James R McIntosh, PhD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion